Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2661566017 | Darifenacin hydrobromide (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2675147016 | Darifenacin hydrobromide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2658851000052112 | darifenacinhydrobromid | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Darifenacin hydrobromide (substance) | Is a | Darifenacin (substance) | false | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Has disposition (attribute) | Muscarinic receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Is modification of (attribute) | Darifenacin (substance) | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Is a | Pyrrolidine | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Is a | Benzofuran (substance) | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Is a | Muscarinic receptor antagonist | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide (substance) | Is a | Antispasmodic (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| darifenacin 7,5 mg, kapsel med modifierad frisättning, tablett | Has active ingredient | False | Darifenacin hydrobromide (substance) | Inferred relationship | Some | |
| darifenacin 15 mg, kapsel med modifierad frisättning, tablett | Has active ingredient | False | Darifenacin hydrobromide (substance) | Inferred relationship | Some | |
| Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | Darifenacin hydrobromide (substance) | Inferred relationship | Some | 1 |
| Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet | Has precise active ingredient | True | Darifenacin hydrobromide (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR